Diosgenin potentiates the anticancer effect of doxorubicin and volasertib via regulating polo-like kinase 1 and triggering apoptosis in hepatocellular carcinoma cells
Article in Naunyn-Schmiedeberg's Archives of Pharmacology (January 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Naunyn-Schmiedeberg's Archives of Pharmacology (January 2024)
Article in Frontiers in Bioscience-Landmark (February 2023)
Article in Cancer Cell International (January 2022)